Clinical Trial Update: Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer

View source ↗

Summary

This document reports a clinical trial evaluating induction therapy with Serplulimab plus chemotherapy for unresectable stage III non-small cell lung cancer, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Unresectable Stage III Non-small-cell Lung Cancer | Status: NOT_YET_RECRUITING